These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24283843)

  • 1. Recombinant allergens for pollen immunotherapy.
    Wallner M; Pichler U; Ferreira F
    Immunotherapy; 2013 Dec; 5(12):1323-38. PubMed ID: 24283843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
    Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
    Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens.
    Valenta R; Linhart B; Swoboda I; Niederberger V
    Allergy; 2011 Jun; 66(6):775-83. PubMed ID: 21352238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergens of weed pollen: an overview on recombinant and natural molecules.
    Gadermaier G; Hauser M; Ferreira F
    Methods; 2014 Mar; 66(1):55-66. PubMed ID: 23806644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From allergen genes to new forms of allergy diagnosis and treatment.
    Vrtala S
    Allergy; 2008 Mar; 63(3):299-309. PubMed ID: 18269675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant allergens and diagnosis of grass pollen allergy.
    Olsen E; Mohapatra SS
    Ann Allergy; 1994 Jun; 72(6):499-506. PubMed ID: 7515604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen-specific immunotherapy with recombinant grass pollen allergens.
    Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
    J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody profiles and self-reported symptoms to pollen-related food allergens in grass pollen-allergic patients from northern Europe.
    Ghunaim N; Grönlund H; Kronqvist M; Grönneberg R; Söderström L; Ahlstedt S; van Hage-Hamsten M
    Allergy; 2005 Feb; 60(2):185-91. PubMed ID: 15647039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoallergenic derivatives of major grass pollen allergens for allergy vaccination.
    Singh MB; Bhalla PL
    Immunol Cell Biol; 2003 Feb; 81(1):86-91. PubMed ID: 12534952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interests of recombinant allergens in the practice of allergy].
    Karoui O; Leimgruber A; Spertini F
    Rev Med Suisse; 2013 Jan; 9(368):22-7. PubMed ID: 23367699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation immunotherapy for tree pollen allergies.
    Su Y; Romeu-Bonilla E; Heiland T
    Hum Vaccin Immunother; 2017 Oct; 13(10):2402-2415. PubMed ID: 28853984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.
    Focke M; Mahler V; Ball T; Sperr WR; Majlesi Y; Valent P; Kraft D; Valenta R
    FASEB J; 2001 Sep; 15(11):2042-4. PubMed ID: 11511525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
    Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
    Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoallergenic mutants of the Timothy grass pollen allergen Phl p 5 generated by proline mutations.
    Wald M; Kahlert H; Reese G; Krontal N; Zafred D; Keller W; Cromwell O; Fiebig H; Nandy A
    Int Arch Allergy Immunol; 2012; 159(2):130-42. PubMed ID: 22653364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant hypoallergens for immunotherapy of Parietaria judaica pollen allergy.
    Asturias JA
    Front Biosci (Landmark Ed); 2009 Jan; 14(12):4606-17. PubMed ID: 19273375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
    Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
    Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.